SVCO vs. DH, DOMO, RZLV, HUYA, CANG, DADA, PERI, LGTY, BAND, and CRNC
Should you be buying Silvaco Group stock or one of its competitors? The main competitors of Silvaco Group include Definitive Healthcare (DH), Domo (DOMO), Rezolve AI (RZLV), HUYA (HUYA), Cango (CANG), Dada Nexus (DADA), Perion Network (PERI), Logility Supply Chain Solutions (LGTY), Bandwidth (BAND), and Cerence (CRNC). These companies are all part of the "computer software" industry.
Silvaco Group vs. Its Competitors
Silvaco Group (NASDAQ:SVCO) and Definitive Healthcare (NASDAQ:DH) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, earnings, dividends, analyst recommendations, risk, valuation and institutional ownership.
98.7% of Definitive Healthcare shares are held by institutional investors. 38.4% of Silvaco Group shares are held by company insiders. Comparatively, 14.8% of Definitive Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Silvaco Group has higher earnings, but lower revenue than Definitive Healthcare. Silvaco Group is trading at a lower price-to-earnings ratio than Definitive Healthcare, indicating that it is currently the more affordable of the two stocks.
In the previous week, Silvaco Group and Silvaco Group both had 2 articles in the media. Silvaco Group's average media sentiment score of 1.39 beat Definitive Healthcare's score of 1.27 indicating that Silvaco Group is being referred to more favorably in the media.
Silvaco Group has a beta of 3.05, meaning that its share price is 205% more volatile than the S&P 500. Comparatively, Definitive Healthcare has a beta of 1.64, meaning that its share price is 64% more volatile than the S&P 500.
Silvaco Group presently has a consensus price target of $15.40, suggesting a potential upside of 255.66%. Definitive Healthcare has a consensus price target of $5.10, suggesting a potential upside of 29.11%. Given Silvaco Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Silvaco Group is more favorable than Definitive Healthcare.
Silvaco Group has a net margin of -103.75% compared to Definitive Healthcare's net margin of -206.05%. Definitive Healthcare's return on equity of 3.69% beat Silvaco Group's return on equity.
Summary
Silvaco Group beats Definitive Healthcare on 9 of the 15 factors compared between the two stocks.
Get Silvaco Group News Delivered to You Automatically
Sign up to receive the latest news and ratings for SVCO and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding SVCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Silvaco Group Competitors List
Related Companies and Tools
This page (NASDAQ:SVCO) was last updated on 7/16/2025 by MarketBeat.com Staff
Free SVCO Stock Alerts